Andrew Schiermeier's Net Worth

$268 Thousand

Estimate Recalculated Sep 8, 2024 07:24PM EST

Who is Andrew Schiermeier?

Andrew Schiermeier does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Intellia Therapeutics, Inc..

SEC CIK

Andrew Schiermeier's CIK is 0001738456

Past Insider Trading and Trends

2020 was Andrew Schiermeier's most active year for acquiring shares with 6 total transactions. Andrew Schiermeier's most active month to acquire stocks was the month of February. 2020 was Andrew Schiermeier's most active year for disposing of shares, totalling 2 transactions. Andrew Schiermeier's most active month to dispose stocks was the month of November. 2019 saw Andrew Schiermeier paying a total of $117,875.00 for 62,500 shares, this is the most they've acquired in one year. In 2021 Andrew Schiermeier cashed out on 1,377 shares for a total of $76,919.22, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Intellia Therapeutics, Inc. (NTLA) Snapshot price: $19.75

EVP, Chief Operating Officer

Andrew Schiermeier owns 16,656 units of Common Stock which is worth $328,956.00. In the year 2018 Andrew Schiermeier filed a total of 9 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 3
Form 4
+25.79%
3.42K
$55.86
-$76,919.22
16.66K
Dec 31 - Jan 5
Form 4
+13.43%
1.5K
$13.48
$20,220.00
12.67K
Dec 30
Form 4
—
0
—
—
0
Jan 3 - Mar 2
Form 4
—
0
—
—
0
Aug 1
Form 4
∞
7.5K
$15.72
$117,875.00
7.5K
Mar 6
Form 4
—
0
—
—
0
Dec 18
Form 4
—
0
—
—
0
May 1
Form 3
—
0
—
—
0
No matching records found